SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $617,400 | +45.9% | 30,000 | +233.3% | 0.00% | 0.0% |
| Q2 2023 | $423,180 | -13.9% | 9,000 | -23.2% | 0.00% | -33.3% |
| Q1 2023 | $491,561 | -85.3% | 11,715 | -86.7% | 0.00% | -85.0% |
| Q4 2022 | $3,350,408 | -13.7% | 87,845 | -11.4% | 0.02% | +25.0% |
| Q3 2022 | $3,881,000 | +817.1% | 99,100 | +1001.1% | 0.02% | +1500.0% |
| Q2 2022 | $423,180 | -20.2% | 9,000 | +22.6% | 0.00% | -50.0% |
| Q4 2019 | $530,000 | -13.1% | 7,341 | +68.9% | 0.00% | -50.0% |
| Q3 2019 | $610,000 | -21.4% | 4,347 | +2.5% | 0.00% | -20.0% |
| Q2 2019 | $776,000 | +9.8% | 4,241 | -4.6% | 0.01% | +25.0% |
| Q1 2019 | $707,000 | +42.3% | 4,447 | -14.3% | 0.00% | +33.3% |
| Q4 2018 | $497,000 | +4.9% | 5,192 | +54.8% | 0.00% | +50.0% |
| Q3 2018 | $474,000 | – | 3,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |